ClinConnect ClinConnect Logo
Search / Trial NCT02960048

Clinical Evaluation of Stabilizing Splint (Michigan-type Occlusal Splint) Versus Anterior Repositioning Splint .

Launched by CAIRO UNIVERSITY · Nov 8, 2016

Trial Information

Current as of June 24, 2025

Unknown status

Keywords

Anterior Disc Displacement Tmd Therapy Internal Derangement Occlusal Splint Anterior Repositioning Splint

ClinConnect Summary

To evaluate the effectiveness of Michigan-type occlusal splint and anterior repositioning splint in patients with temporomandibular joint anterior disc displacement with reduction.

PICO:

Population (P): Patients with symptomatic anterior disc displacement with reduction.

Intervention (I): Michigan splint. Comparator (C): Anterior repositioning splint (ARS) .

Outcome(O):

Primary outcome: Patients' subjective pain experience. Each patient will be asked to rate his or her current and worst pain intensity on numerical rating scale (NRS) of 0-10 with zero being no pain and ten corresponds t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adult patient from 15 to 50 years old.
  • 2. Report of pain in preauricular region worsened by functional activities, such as chewing and talking.
  • 3. Presence of disc displacement with reduction and joint clicking
  • 4. positive diagnosis of unilateral or bilateral anterior disc displacement with reduction by means of magnetic resonance imaging (MRI).
  • Exclusion Criteria:
  • 1. . .
  • 2. History of TMJ surgery.
  • 3. Individuals with osteoarthritis.
  • 4. Individuals under TMD management.
  • 5. Individuals wearing full or partial dentures.
  • 6. Individuals with major psychological disorders.
  • 7. Nonreducing dislocations of the articular disc
  • 8. Consequences of condyle fractures and/or fracture of another maxillofacial zone.
  • 9. Articular pathologies of systemic nature (e.g., rheumatoid arthritis, arthrosis, psoriasis arthritis).
  • 10. Individuals with a recent history of trauma in the face and/or neck area. Individuals with systemic diseases that can affect TMJ

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Patients applied

0 patients applied

Trial Officials

Nadia Galal, MD

Study Director

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials